ApoE signaling modulator (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ApoE signaling modulator (investigational), covering 2024-09-04 to 2024-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Modulating ApoE Signalling to Reduce Brain Inflammation, deLirium and postopErative Cognitive Dysfunction [Phase 2]